Selective inhibition of microbial serine proteases by eNAP-2, an antimicrobial peptide from equine neutrophils.

AUTOR(ES)

Couto, M A

RESUMO

Equine neutrophil antimicrobial peptide 2 (eNAP-2), a recently described antimicrobial peptide isolated from equine neutrophils, was found to selectively inactivate microbial serine proteases (subtilisin A and proteinase K) without inhibiting mammalian serine proteases (human neutrophil elastase, human cathepsin G, and bovine pancreatic trypsin). Although the primary structure of eNAP-2 resembled that of several known antiproteases that belong to the 4-disulfide core peptide family, this pattern of selectivity is unique. eNAP-2 formed a noncovalent complex with native subtilisin A or proteinase K but did not associate with these enzymes if they had been treated with phenylmethylsulfonyl fluoride, a serine protease inhibitor. The eNAP-2-microbial protease complex was disrupted by boiling or by exposure to low pH. We suggest that eNAP-2 exerted selective antiproteinase activity by binding tightly but noncovalently to the active site of subtilisin A or proteinase K. Since microbial exoproteases may act as virulence factors, the combined antimicrobial and antiprotease activities of eNAP-2 could allow it to play an important role in neutrophil-mediated antimicrobial defenses.

Documentos Relacionados

• Identification of eNAP-1, an antimicrobial peptide from equine neutrophils.
• eNAP-2, a novel cysteine-rich bactericidal peptide from equine leukocytes.
• Azurocidin and a homologous serine protease from neutrophils. Differential antimicrobial and proteolytic properties.
• Inhibition by prostaglandins of leukotriene B4 release from activated neutrophils.
• Purification and antimicrobial properties of three defensins from rat neutrophils.